SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-029509
Filing Date
2021-05-24
Accepted
2021-05-24 16:10:27
Documents
12
Period of Report
2021-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K beam-8k_20210520.htm   iXBRL 8-K 33458
  Complete submission text file 0001564590-21-029509.txt   162388

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA beam-20210520.xsd EX-101.SCH 5768
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE beam-20210520_lab.xml EX-101.LAB 19470
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE beam-20210520_pre.xml EX-101.PRE 11625
5 EXTRACTED XBRL INSTANCE DOCUMENT beam-8k_20210520_htm.xml XML 3546
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39208 | Film No.: 21955008
SIC: 2836 Biological Products, (No Diagnostic Substances)